Chunying Shen - Search Results

Year	Number of Results
2002	1
2008	2
2009	2
2011	2
2012	2
2014	3
2015	2
2016	4
2017	4
2018	13
2019	6
2020	3
2021	5
2022	6
2023	8
2024	1

1

Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial.

Sun Y, Li WF, Chen NY, Zhang N, Hu GQ, Xie FY, Sun Y, Chen XZ, Li JG, Zhu XD, Hu CS, Xu XY, Chen YY, Hu WH, Guo L, Mo HY, Chen L, Mao YP, Sun R, Ai P, Liang SB, Long GX, Zheng BM, Feng XL, Gong XC, Li L, Shen CY, Xu JY, Guo Y, Chen YM, Zhang F, Lin L, Tang LL, Liu MZ, Ma J. Sun Y, et al. Lancet Oncol. 2016 Nov;17(11):1509-1520. doi: 10.1016/S1470-2045(16)30410-7. Epub 2016 Sep 27. Lancet Oncol. 2016. PMID: 27686945 Clinical Trial.

2

CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus-Driven Oropharyngeal Cancer.

Wei Y, Xu T, Li C, Zhou X, Qian W, Shen C, Wang Q, Xing X, Ou X, He X, Yin H, Hu C, Wang Y, Ji Q, Su F, Lu X. Wei Y, et al. Among authors: shen c. Cancer Immunol Res. 2023 Mar 1;11(3):306-319. doi: 10.1158/2326-6066.CIR-22-0454. Cancer Immunol Res. 2023. PMID: 36633583 Free PMC article.

3

Prognostic value of circulating Epstein-Barr virus DNA level post-induction chemotherapy for patients with nasopharyngeal carcinoma: A recursive partitioning risk stratification analysis.

Kong FF, Pan GS, Du CR, Ni MS, Zhai RP, He XY, Shen CY, Lu XG, Hu CS, Ying HM. Kong FF, et al. Radiother Oncol. 2023 Aug;185:109721. doi: 10.1016/j.radonc.2023.109721. Epub 2023 May 25. Radiother Oncol. 2023. PMID: 37244356

4

Response to induction chemotherapy predicts survival outcomes in oropharyngeal cancer.

Zhang Q, Xu T, Shen C, Qian W, Ying H, He X, Wang Y, Ji Q, Hu C, Zhou X, Lu X. Zhang Q, et al. Among authors: shen c. Cancer Med. 2023 Apr;12(8):9175-9185. doi: 10.1002/cam4.5656. Epub 2023 Jan 27. Cancer Med. 2023. PMID: 36708134 Free PMC article.

5

Selective Treatment Deintensification by Reducing Radiation Dose and Omitting Concurrent Chemotherapy Based on Response to Induction Chemotherapy in Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma: A Single-Arm, Phase 2 Trial (IChoice-01).

Xu T, Shen C, Zhou X, Zhu L, Xiang J, Wang Y, Zhu Y, He X, Ying H, Wang Y, Ji Q, Hu C, Lu X. Xu T, et al. Among authors: shen c. Int J Radiat Oncol Biol Phys. 2024 Jan 1;118(1):169-178. doi: 10.1016/j.ijrobp.2023.07.037. Epub 2023 Aug 12. Int J Radiat Oncol Biol Phys. 2024. PMID: 37574169 Free article. Clinical Trial.

6

Dissecting the heterogeneity of the microenvironment in primary and recurrent nasopharyngeal carcinomas using single-cell RNA sequencing.

Peng WS, Zhou X, Yan WB, Li YJ, Du CR, Wang XS, Shen CY, Wang QF, Ying HM, Lu XG, Xu TT, Hu CS. Peng WS, et al. Oncoimmunology. 2022 Jan 25;11(1):2026583. doi: 10.1080/2162402X.2022.2026583. eCollection 2022. Oncoimmunology. 2022. PMID: 35096485 Free PMC article.

7

Influencing Factors of Porosity and Strength of Plant-Growing Concrete.

Cai J, Shen C, Ye M, Huang S, He J, Cui D. Cai J, et al. Among authors: shen c. Materials (Basel). 2023 Dec 20;17(1):31. doi: 10.3390/ma17010031. Materials (Basel). 2023. PMID: 38203885 Free PMC article.

8

Frailty in Community-Dwelling Adults Aged 40 Years and over with Type 2 Diabetes: Association with Self-Management Behaviors.

Tang Z, Shen C, Tong W, Xiang X, Feng Z, Han B. Tang Z, et al. Among authors: shen c. Int J Environ Res Public Health. 2022 Jul 26;19(15):9092. doi: 10.3390/ijerph19159092. Int J Environ Res Public Health. 2022. PMID: 35897460 Free PMC article.

9

Prediction of Drug-Drug Interactions with Ensartinib as a Time-Dependent CYP3A Inhibitor Using Physiologically Based Pharmacokinetic Model.

Wang X, Yu Y, Liu H, Bu F, Shen C, He Q, Zhu X, Jiang P, Han B, Xiang X. Wang X, et al. Among authors: shen c. Drug Metab Dispos. 2023 Nov;51(11):1515-1526. doi: 10.1124/dmd.123.001373. Epub 2023 Aug 29. Drug Metab Dispos. 2023. PMID: 37643879

10

Circulating tumor DNA detectable in early- and late-stage colorectal cancer patients.

Yang YC, Wang D, Jin L, Yao HW, Zhang JH, Wang J, Zhao XM, Shen CY, Chen W, Wang XL, Shi R, Chen SY, Zhang ZT. Yang YC, et al. Biosci Rep. 2018 Jul 31;38(4):BSR20180322. doi: 10.1042/BSR20180322. Print 2018 Aug 31. Biosci Rep. 2018. PMID: 29914973 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

60 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year